The Lydia Becker Institute of Immunology and Inflammation, along with the MRC CoRE in Exposome Immunology, has announced the appointment of leading immunologist and cytokine biologist Prof. Sarah Gaffen as the new institute director. Professor Sarah Gaffen will join...
The Lydia Becker Institute of Immunology and Inflammation and the MRC CoRE in Exposome Immunology are partnering with the Manchester Institute of Biotechnology (MIB) to launch the Manchester Immuno-Biotechnology Initiative (MImmBI)While Manchester hosts world-leading...
The Lydia Becker Institute at The University of Manchester is delighted to announce that Professor Mahima Swamy will be joining the Institute as a Professor of Immunology from August 1st, expanding the Becker’s world-class expertise in Barrier Immunity. Her lab...
On Saturday 13 June, the Lydia Becker Institute brought the world of immunology out of the lab and into the community by taking part in The University of Manchester’s Community Fair at University Place, part of the Universally Manchester Festival. This vibrant, annual...
British Science Week is a nationwide celebration of STEM and marks a brilliant opportunity for outreach. On 9 and 10 March, Manchester Museum became a hub of fascinating research. Over 100 researchers from diverse disciplines set up stalls to bring the science out of...
The Academy of Medical Sciences (AMS) has awarded a prestigious Springboard Award to the Lydia Becker Institute's Dr Sara Federici, supporting her work as an independent early-career researcher at The University of Manchester. The AMS Springboard scheme provides up to...
The British Society for Immunology recently held its committee elections for 2026. Two Lydia Becker researchers have been elected to represent early career researchers in the Member Engagement Forum.Dr Stephane Guillaume will be serving as the Early Career...
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a “masked T-cell engager”. This type of immunotherapy ignites our own immune arsenal to fight cancer.In the trial, which is still in...
Following the recent meningitis B outbreak in Kent, Professor Jeremy Derrick, an expert in molecular microbiology affiliated with the Lydia Becker Institute of Immunology and Inflammation, spoke with the Manchester Evening News to explain why this pathogen remains...
Stroke is a potentially fatal neurological event that is increasingly prevalent across the globe. While rapid clinical interventions are urgently needed to reduce acute mortality, stroke survivors also suffer from a wide range of secondary and long-lasting health...
